Stay updated on Ecztra 4: Tralokinumab Drug Interaction Clinical Trial
Sign up to get notified when there's something new on the Ecztra 4: Tralokinumab Drug Interaction Clinical Trial page.

Latest updates to the Ecztra 4: Tralokinumab Drug Interaction Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page has been updated to include new drug information related to Atopic Dermatitis, specifically mentioning Omeprazole, Metoprolol, and Midazolam Hydrochloride, while significant details about the trial's purpose and inclusion/exclusion criteria have been removed.SummaryDifference26%
- Check29 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for February 24, 2025, while a previous date of March 25, 2025, has been removed.SummaryDifference0.5%
- Check73 days agoChange DetectedThe webpage has updated its last update dates to February 2025 and removed previous update dates from October 2024. Additionally, it has removed information regarding heavy traffic affecting NLM-NCBI services and details about IPD Sharing Access Criteria.SummaryDifference4%
- Check87 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference2%
- Check94 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
Stay in the know with updates to Ecztra 4: Tralokinumab Drug Interaction Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ecztra 4: Tralokinumab Drug Interaction Clinical Trial page.